<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6843332/results/search/test_trace/results.xml">
  <result pre="threatening encephalitis, including cancers associated with viral infections. The current" exact="treatment" post="options for most HHV conditions mainly include several nucleoside"/>
  <result pre="immune compromised individuals, and is the leading cause of post-transplant" exact="infection" post="[6,7]. Congenital CMV results in an estimated 8000 cases"/>
  <result pre="year, affecting over 90% of infants who survive the initial" exact="infection" post="[8,9,10]. Chicken pox and shingles, caused by varicella-zoster virus"/>
  <result pre="polymerase pUL54 mediate resistance to ganciclovir and valganciclovir [25]. The" exact="prevalence" post="of resistance against acyclovir is 5% in immunocompromised persons"/>
  <result pre="or MK-8228), is another promising new antiviral drug for the" exact="treatment" post="of CMV. Letermovir is believed to inhibit the viral"/>
  <result pre="keratitis meningitis, encephalitis, and HHV-2 increases the likelihood of HIV" exact="infection" post="by three-fold [83]. The ability of HHV to establish"/>
  <result pre="ADP while 2o0h was bound to ATP. Furthermore, fingerprint-based virtual" exact="screening" post="conducted with eFindSite suggests that this binding pocket is"/>
  <result pre="viral strategies and host responseJ. Oral. Microbiol.201352276610.3402/jom.v5i0.2276624167660 6.KottonC.N.Management of cytomegalovirus" exact="infection" post="in solid organ transplantationNat. Rev. Nephrol.2010671172110.1038/nrneph.2010.14120978468 7.WhitleyR.J.HerpesvirusesMedical Microbiology4th ed.BaronS.University"/>
  <result pre="ed.BaronS.University of Texas Medical BranchGalveston, TX, USA1996 8.BoppanaS.B.FowlerK.B.BrittW.J.StagnoS.PassR.F.Symptomatic congenital cytomegalovirus" exact="infection" post="in infants born to mothers with preexisting immunity to"/>
  <result pre="virus type 1 (HHV-1) genome, mining of non-canonical structures and" exact="detection" post="of novel drug-resistance mutations using short- and long-read next"/>
  <result pre="Virol.200326293710.1016/S1386-6532(02)00263-912589832 27.LurainN.S.ChouS.Antiviral drug resistance of human cytomegalovirusClin. Microbiol. Rev.20102368971210.1128/CMR.00009-1020930070 28.SchreiberA.HarterG.SchubertA.BunjesD.MertensT.MichelD.Antiviral" exact="treatment" post="of cytomegalovirus infection and resistant strainsExpert. Opin. Pharmacother.20091019120910.1517/1465656080267813819236193 29.YangL.YangQ.WangM.JiaR.ChenS.ZhuD.LiuM.WuY.ZhaoX.ZhangS.et"/>
  <result pre="resistance of human cytomegalovirusClin. Microbiol. Rev.20102368971210.1128/CMR.00009-1020930070 28.SchreiberA.HarterG.SchubertA.BunjesD.MertensT.MichelD.Antiviral treatment of cytomegalovirus" exact="infection" post="and resistant strainsExpert. Opin. Pharmacother.20091019120910.1517/1465656080267813819236193 29.YangL.YangQ.WangM.JiaR.ChenS.ZhuD.LiuM.WuY.ZhaoX.ZhangS.et al.Terminase large subunit"/>
  <result pre="stem cell transplant recipientsAntimicrob. Agents Chemother.2015593718372510.1128/AAC.04348-1425733509 46.ChenK.ChengM.P.HammondS.P.EinseleH.MartyF.M.Antiviral prophylaxis for cytomegalovirus" exact="infection" post="in allogeneic hematopoietic cell transplantationBlood Adv.201822159217510.1182/bloodadvances.201801649330154125 47.ClarkK.Karsch-MizrachiI.LipmanD.J.OstellJ.SayersE.W.GenBankNucleic Acids Res.201644677210.1093/nar/gkv127626590407"/>
  <result pre="auxiliary ligandsJ. Comput. Aided. Mol. Des.20132755156710.1007/s10822-013-9663-523838840 71.FeinsteinW.P.BrylinskiM.eFindSite: Enhanced fingerprint-based virtual" exact="screening" post="against predicted ligand binding sites in protein modelsMol. Inform.20143313515010.1002/minf.20130014327485570"/>
 </snippets>
</snippetsTree>
